M. Montero
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Use and Resistance 20
-
- Antibiotic Resistance in Bacteria 45
- Co-authors
- Juan Pablo HorcajadaLuisa SorlíSantiago GrauSònia LuqueHernando KnobelNatividad BenitoAntonio OliverSílvia Gómez-Zorrilla
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (4 papers)Microbiology Spectrum (4 papers)Journal of Infection (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)International Journal of Antimicrobial Agents (3 papers)
- Partner nations
- SpainAustraliaUnited States
In The Last Decade
M. Montero
82 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Medicine 1.3k
- Applied Microbiology and Biotechnology 511
- Virology 200
- Emergency Medicine 406
- Endocrinology 212
Countries citing papers authored by M. Montero
This map shows the geographic impact of M. Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Montero more than expected).
Fields of papers citing papers by M. Montero
This network shows the impact of papers produced by M. Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Montero. The network helps show where M. Montero may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Montero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 34 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 2 | |
| 12 | 2019 | 14 | |
| 13 | 2019 | 8 | |
| 14 | Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections Hit paper breakdown → | 2019 | 625 |
| 15 | 2017 | 34 | |
| 16 | In Vitro Activity of Ceftazidime and Meropenem in Combination with Tobramycin or Ciprofloxacin in A Clone of Multiresistant Pseudomonas Aeruginosa | 2013 | 1 |
| 17 | 2013 | 188 | |
| 18 | Pseudomonas aeruginosa multiresistente aspectos epidemiológicos, clínicos y terapéuticos | 2012 | 1 |
| 19 | Factores predictivos de neumonía en pacientes infectados por el nuevo virus de la gripe A (H1N1) pandémica | 2011 | 5 |
| 20 | 2010 | 36 |
About M. Montero
M. Montero is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Virology and Infectious Diseases, having authored 89 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (32 papers), Antibiotic Use and Resistance (20 papers), HIV-related health complications and treatments (12 papers), Pneumonia and Respiratory Infections (12 papers), HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Urinary Tract Infections Management (8 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Applied Microbiology and Biotechnology (511 citations), Virology (200 citations), Emergency Medicine (406 citations) and Endocrinology (212 citations). M. Montero has collaborated with scholars based in Spain, Australia and United States. Frequent co-authors include Juan Pablo Horcajada, Luisa Sorlí, Santiago Grau, Sònia Luque, Hernando Knobel, Natividad Benito, Antonio Oliver, Sílvia Gómez-Zorrilla, Ana Guelar and Francisco Álvarez-Lerma. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Microbiology Spectrum, Journal of Infection, Antimicrobial Agents and Chemotherapy and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.